$8.5M sweet spot round size
Most of their 10 investments are in rounds between $3M and $13M
1989
Spine BioPharma raised $13M on February 8, 2023
Investors: Cercano Management, Viscogliosi Bros., LLC and Pacira Pharmaceuticals
CarthroniX raised $2.3M on April 11, 2022
Investors: Pacira Pharmaceuticals
Spine BioPharma raised $13M on March 28, 2022
Investors: Cercano Management, Viscogliosi Bros., LLC and Pacira Pharmaceuticals
Genascence Corporation raised $11M on January 7, 2022
Investors: Personnel Administrative Svcs, FAN Fund and Pacira Pharmaceuticals
CODA Biotherapeutics raised $28M on December 2, 2021
Investors: MPM Capital, Versant Ventures and Pacira Pharmaceuticals
Spine BioPharma raised $3M on April 20, 2021
Investors: Pacira Pharmaceuticals
GeneQuine Biotherapeutics raised $3.4M on February 15, 2021
Investors: Pacira Pharmaceuticals
GeneQuine Biotherapeutics raised $6.5M on February 15, 2021
Investors: High-Tech Gründerfonds, - and Pacira Pharmaceuticals
Avalon AI raised $1.5M on August 28, 2020
Investors: Pacira Pharmaceuticals
TELA Bio raised $25M on October 30, 2017
Investors: Signet Healthcare Partners, OrbiMed Advisors and Pacira Pharmaceuticals
$85M
from 4 investors over 4 rounds
Pacira Pharmaceuticals raised $28M on May 3, 2012
Investors: Oxford Finance LLC
Pacira Pharmaceuticals raised $85M on November 17, 2008
Investors: MPM Capital, Sanderling Ventures and OrbiMed Advisors